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ABSTRACT 
Background: Infective rhinosinusitis is a common clinical condition which if left unattended to could result in various 
degrees of both morbidity and mortality. We aimed to identify aerobic and fungal organisms implicated in acute and 
chronic maxillary sinusitis and determine their antibiotic sensitivity patterns among adults in South Western Nigeria.   
Materials and methods: This was a cross sectional study of adults with clinical and radiological diagnosis of maxillary 
sinusitis treated at the University College Hospital, Ibadan over a period of one-year. Semi- structured questionnaire was 
administered to each consented adult to obtain relevant demographic and clinical data. Maxillary antral proof puncture was 
done to obtain specimen for microscopy, culture and sensitivity for aerobic bacterial and fungal isolates. Descriptive 
statistics was used in the data analysis.  
Results: Seventy-nine patients (49.4% males and 50.6% females) with acute maxillary sinusitis (17.7%), and chronic 
maxillary sinusitis (82.3%) were recruited into the study. The mean age of the patients was 32.9 years (SD=12.78; Range: 19-
59). All patients presented with rhinorrhea while 92.8% had nasal obstruction. Fifty eight (73.4%) patients had history of 
antibiotic usage before presentation. Eight (57.1%) of the specimens from acute maxillary sinusitis cases and 40 (61.5%) of 
the specimens from chronic maxillary sinusitis yielded significant growth of bacteria and fungi respectively while 2 (3.5%) 
yielded mixed bacterial growth. Organisms commonly isolated from these specimens were Streptococcus pneumonia, 
Staphylococcus aureus, Pseudomonas aeruginosa, Haemophilus influenzae, and Aspergillus spp. The bacteria isolates were 
sensitive to Amoxicillin, Ciprofloxacin, Perfloxacin, Sparfloxacin and Ceftriaxone.  
 
Conclusion: The leading aerobic bacterial isolates from acute and chronic maxillary sinusitis were Streptococcus pneumonia 
and Staphylococcus aureus respectively. Fungal infections are seen only in chronic cases. It is recommended that where 
there are no microbiologic laboratory facilities, any of Ciprofloxacin, Perfloxacin, Sparfloxacin, and Amoxicillin can be 
administered empirically to treat infective maxillary sinusitis. 
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RÉSUMÉ 
Contexte : rhinosinusite infectieuse est une condition clinique commun qui si laissé sans surveillance à pourrait donner 
lieu à des degrés divers de la morbidité et de la mortalité. Nous avons pour but d'identifier les organismes aérobies et 
fongiques impliqués dans la sinusite maxillaire aiguë et chronique et de déterminer leur sensibilité aux antibiotiques chez 
les adultes dans le sud-ouest du Nigeria. 
Matériels et méthodes : Il s'agissait d'une étude transversale des adultes avec le diagnostic clinique et radiologique de la 
sinusite maxillaire traités à l'Hôpital du Collège universitaire, Ibadan sur une période d'un an.  Semi- questionnaire 
structuré a été administré à chaque consenti des profils pour obtenir les données démographiques et cliniques.  
 






La preuve de l'antre maxillaire crevaison a été fait pour obtenir l'échantillon pour la microscopie, la culture et la sensibilité 
pour les isolats fongiques et bactériennes aérobies. La statistique descriptive a été utilisé dans l'analyse des données. 
 
Résultats : Soixante-neuf patients (49,4  % d'hommes et 50,6  % de femmes) avec une sinusite maxillaire aiguë (17,7  %), et la 
sinusite maxillaire chronique (82,3  %) ont été recrutés dans l'étude. L'âge moyen des patients était de 32,94 ans (ET  = 12,78 ; 
Plage : 19-59). Tous les patients présentaient une rhinorrhée tandis que 92,8 % avaient l'obstruction nasale. Cinquante huit 
(73,4 %) patients avaient histoire de l'utilisation des antibiotiques avant la présentation. Huit (57,1  %) des échantillons de 
la sinusite maxillaire aiguë et 40 cas (61,5  %) des échantillons de la sinusite maxillaire chronique ont produit une croissance 
importante de bactéries et de champignons respectivement, tandis que 2 (3,5  %) a donné la croissance bactérienne mixte. 
Souvent les organismes isolés de ces spécimens ont été Streptococcus pneumonie, Staphylococcus aureus, Pseudomonas 
aeruginosa, Haemophilus influenzae, et de l'Aspergillus spp. Les bactéries étaient sensibles à l'Amoxicilline, la 
ciprofloxacine, Perfloxacin, la sparfloxacine et la ceftriaxone. 
Conclusion : Le leader des isolats bactériens aérobies de sinusite maxillaire aiguë et chronique ont été Staphylococcus 
aureus Streptococcus pneumonie et respectivement. Organismes fongiques ne sont observées que dans les cas chroniques. 
Il est recommandé que, lorsqu'il n'y a pas d'installations de laboratoire microbiologique, l'autre de la Ciprofloxacine, 
Perfloxacin, la sparfloxacine, et de l'amoxicilline peut être administré de manière empirique pour traiter la sinusite 
maxillaire infectieux. 
 
Mots clés : aérobie des bactéries, champignons, du sinus maxillaire rhinosinusite, 
 
INTRODUCTION 
Infective rhinosinusitis is a common clinical 
condition which if left untreated could result in 
various degrees of both morbidity and mortality (1, 
2). It may start as non-infective rhinosinusitis and 
later become infected with bacteria. Often, there is 
involvement of more than one paranasal sinus but 
maxillary sinus is the most commonly affected. 
Treatment of infective rhinosinusitis with 
appropriate antibiotics can prevent complications 
and result in a satisfactory management outcome 
(3).  
In Nigeria, antibiotics are readily available for 
procurement in the open market for usage because 
there is no enforcement of the laid down policies 
that restrict individuals or patients from having 
direct access to it without doctor’s prescription. 
This injudicious antibiotics usage might induce 
growth of resistant bacterial strain with microbial 
dynamism in infective maxillary sinusitis (4, 5). 
Furthermore, abuse of antibiotics can lead to 
replacement of microbial organisms by fungal 
organisms (5). 
There is paucity of literature on the current infective 
agents implicated in maxillary sinusitis and no 
agreed antibiotic regimen for the empirical 
treatment of infective rhinosinusitis in Nigeria. 
These have led to the injudicious antibiotic usage by 
the patients with resultant microbial dynamism. In 
addition, the relative lack of anti-bacteriological 
sensitivity pattern for infective maxillary sinusitis 
has caused uncertainty on the part of the clinicians 
in the choice of the most appropriate antibiotics to 
be administered as first line therapy where medical 
laboratory facility is unavailable. The increasing 
rates of antimicrobial resistance following abuse 
and misuse of antibiotics hamper logical treatment 
strategies. This makes it impossible to know which 
cases of maxillary sinusitis will spontaneously 
resolve or not hence, trial and error antimicrobial 
prescription on the part of clinicians is routinely 
practiced. 
 
When patients have signs suggestive of infective 
rhinosinusitis, most of the time, they would have 
used antibiotics indiscriminately and only when 
there is no improvement in their clinical condition 
that they present to the Clinicians, especially 
Otolaryngologists where available (6). At this stage, 
it is only by performing microscopy, culture and 
sensitivity test on the aspirate obtained directly 
from the maxillary antrum or middle meatus of 
such patients that the exact organisms responsible 
for the infection can be isolated and the 
antimicrobial sensitivity pattern known (7, 8). 
 
Infective rhinosinusitis could result in serious 
morbidity and complications if neglected or 
inappropriately treated. The aims of this study were 
to isolate the pathogenic aerobic bacterial and 
fungal organisms that are implicated in maxillary 
sinusitis among adults in South Western Nigeria as 
well as to determine their antibiotic sensitivity 
pattern. This would be borne in mind in the 
selection of empirical treatment pending the result 
of microscopy, culture and sensitivity for aerobic 
bacteria and in environment where there is no easy 
access to microbiologic laboratory facility. 
 
METHODOLOGY 
Study design: This was a prospective hospital-
based, cross sectional study of adults with maxillary 
sinusitis managed at the Department of 
Otorhinolaryngology, University College Hospital, 
Ibadan. Ethical approval was obtained from 
UI/UCH Ethical Review Board to conduct the 
study. An understood, written and verbal informed 
consent was obtained from all the participants and 
sample collection was conducted in accordance 
with the Helsinki Declaration of 1975 as revised in 
1996. Participants were adults, 18 years old and 
above, with clinical and radiological diagnosis of 
maxillary sinusitis (9). 
 
Data Collection procedures 
Questionnaire: A structured interview assisted 
questionnaire was administered to collect the 
participants’ demographic and relevant clinical data 
of acute and chronic rhinosinusitis (10). Clinical 




or more major factors or 1 major factor and 2 minor 
factors (9).  
Radiologic evaluation: Plain radiography of the 
paranasal sinuses (Occipitomental, occipitofrontal 
and lateral views) was performed on all the 
participants. The radiological features of maxillary 
sinusitis included haziness or opacification of 
maxillary antrum, gross mucosal thickening and/or 
presence of fluid level in the maxillary antrum (11). 
Bacteriology and mycology: The maxillary antral 
specimen was obtained by aspiration through an 
inferior meatal antrostome created under good 
illumination using standard sterile and anesthetic 
procedures. Whenever there was a negative 
aspiration, 3-5mls of normal saline at body 
temperature was injected into the maxillary antrum 
and subsequently aspirated again (12). The 
maxillary sinus aspirates from the more affected 
antrum in a participant was sent immediately for 
microscopy, culture and sensitivity for aerobic 
bacterial and fungal studies in the diagnostic 
laboratory of the Department of Medical 
Microbiology, University College Hospital, Ibadan.  
 
The antral aspirate of each patient was inoculated 
on Sheep blood and MacConkey agar for the culture 
of the aerobic bacterial organisms. Inoculated plates 
were then incubated aerobically at 37oC for 18-24 
hrs. Bacterial isolates from these specimens were 
identified using standard bacteriological methods 
(13), and were then subjected to antibiotics 
susceptibility testing following the Clinical and 
Laboratory Standard Institute (CLSI) for the disc 
diffusion test (14).  Pathogenicity of the isolated 
organism was determined using established 
pathogenic properties such as production of toxins 
and/or other virulence factors, and dominance of 
the organism in the infecting flora (103cfu/ml). Part 
of the same specimen was also cultured for fungal 
organisms on Sabouraud Dextrose Agar at room 
temperature for 3 weeks and thereafter stained with 
lactophenol cotton blue for fungi identification if 
present. We performed disc susceptibility testings’ 
on cefuroxime (30ug), augumentin (10ug), 
amoxicillin (10ug), cloxacillin (10ug) erythromycin 
(30ug), ceftriaxone (30ug), ceftazidime (30ug), 
ciprofloxacin (5ug), ofloxacin (5ug), gentamycin 
(10ug) and Sparfloxacin (5ug). These antibiotics are 
readily available for use in our environment. The 
susceptibility patterns of the drugs were interpreted 
according to standard methods (14).  Part of the 
antral aspirate of each patient was inoculated on 
Sabouraud Dextrose Agar and incubated at 37oC for 
48hrs and room temperature for up to 3 weeks.  The 
diagnosis of fungal infection was made on the basis 
of the recognisable and characteristic appearance of 
fungal hyphae fruiting bodies after staining with 
lacto phenol cotton blue under microscopy.   
Data analysis: Data collected were collated and 
analyzed using Statistical Package for the Social 
Sciences (SPSS) version 18. The results were then 
presented in descriptive format, tables, diagrams 
and graphs where appropriate.  P value of < 0.05 
was considered as statistically significant.  
 
RESULTS 
Seventy-nine patients (49.4% males and 50.6% 
females) with acute maxillary sinusitis and chronic 
maxillary sinusitis were recruited into the study. 
The mean age of the patients was 32.94 years 
(SD=12.78; Range: 19-59). Fourteen (17.70%) 
patients had acute rhinosinusitis and 65 (82.30%) 
had chronic rhinosinusitis. Fifty-eight (73.40%) 
patients had history of antibiotic usage before 
presentation. The clinical presentation of patients 
with acute rhinosinusitis and chronic rhinosinusitis 
are shown in tables 1 and 2 respectively.  
 
TABLE 1: CLINICAL PRESENTATIONS OF THE 
PATIENTS WITH ACUTE RHINOSINUSITIS 
Symptoms Frequency (N) Percentage (%) 







Fatigue 8 57.14 
Stuffy nose 8 57.14 
Fever 7 50.00 
Hyposmia/anosmia 2 14.29 
Ear pain 2 14.29 
Halitosis 1 7.14 




TABLE 2: CLINICAL PRESENTATIONS OF PATIENTS 
WITH CHRONIC RHINOSINUSITIS 
Symptoms Frequency (N) Percentage (%) 




Itching of eye or ear or 
nose or  throat 
44 89.80 
Frequent throat hawking 
& clearing 
43 75.44 
Excessive sneezing 37 64.91 
Hyposmia/anosmia 9 15.79 
Facial pain/pressure or 
headache 
7 12.28 
Fatigue 5 8.77 
Ear pain 5 8.77 
Tooth ache 4 7.02 
Cheek pain 4 7.02 
Hoarseness 4 7.02 
Halitosis 3 5.26 





The diagnosis of maxillary sinusitis was further 
confirmed with plain radiographs of the paranasal 
sinuses. Mucosal thickening was found in 47 
(59.49%) patients, opacification of the maxillary 
antrum in 29 (36.71%) patients and fluid level in 3 
(3.80%) patients. Fluid level was found only on the 
Water’s view of patients with acute maxillary 
sinusitis. Only one patient with acute maxillary 
sinusitis has radiologic evidence of bilateral 
maxillary antral opacity while four patients with 
chronic maxillary sinusitis had bilateral maxillary 
antral opacity. 
Out of the 14 specimens from the maxillary antrum 
of the patients with acute maxillary sinusitis, 8 
(57.14%) yielded bacterial growth (Table 3). None of 
the specimen yielded fungal growth.  
However, of the 65 specimens from the maxillary 
antrum of patients with chronic maxillary sinusitis, 
only 40 (61.54%) yielded significant aerobic 
bacterial isolates (Table 4) while 7 (14.58%) yielded 
fungal isolates (Table 5). Two (3.51%) specimens 
yielded mixed bacteria growth. Twenty five 
(38.46%) specimens did not grow any bacteria.  
 
TABLE 3: BACTERIA ISOLATES FROM ANTRAL SPECIMENS OF PATIENTS WITH ACUTE MAXILLARY SINUSITIS 
 Bacteria isolated Frequency(N) Percentage (%) Total 
Gram Positive Streptococcus pneumonia  4 50.00 N = 5 
(62.50%) Staphylococcus aureus 1 12.50 
Gram Negative Haemophilus influenza 3 37.50 N = 3 
(37.50%) 




TABLE 4: BACTERIA ISOLATES FROM ANTRAL SPECIMENS OF PATIENTS WITH CHRONIC MAXILLARY 
SINUSITIS 
        Bacteria isolated Frequency (N) Percentage (%) Total 
















N = 19 
(45.24%) 
 













N = 23 
(54.76%) 
Total  42 100.00 41(100%) 
 
 
TABLE 5: FUNGI ISOLATES FROM ANTRAL SPECIMENS OF PATIENTS WITH CHRONIC MAXILLARY SINUSITIS 
Fungal isolates Frequency Percentage (%) 
Aspergillus flavus 3 42.86 
Aspergillus fumigatus 2 28.57 
Candida albicans 2 28.57 
Total 7 100.00 
 
 
The antibiotic sensitivity patterns of the cultured aerobic bacterial organisms are presented in Tables 6 and 7. 
 
 
TABLE 6: ANTIBIOTIC SENSITIVITY PATTERN OF AEROBIC BACTERIA CULTURED FROM THE ANTRAL 
ASPIRATES OF PATIENTS WITH ACUTE MAXILLARY SINUSITIS 
Bacteria isolates from 
acute maxillary antral 
specimen 
In vitro antibiotic sensitivity [n (%)] 























Staphylococcus aureus  1 
(100) 
































1 = Pefloxacin, 2 = Ciprofloxacin, 3 = Ofloxacin, 4 = Gentamycin, 5 = Augumentin, 6 = Amoxicillin, 7 = Cloxacillin, 8 = 





TABLE 7: ANTIBIOTIC SENSITIVITY PATTERN OF AEROBIC BACTERIA CULTURED FROM THE ANTRAL 
ASPIRATES OF PATIENTS WITH CHRONIC MAXILLARY SINUSITIS 
Bacteria isolates from 
chronic maxillary antral 
specimen 
In vitro antibiotic sensitivity [n (%)] 
1 2 3 4 5 6 7 8 9 10 12 
Staphylococcus aureus  9 (100) 8 (88.9) 7 (77.8) 3 (33.3) 8 (88.9) 9 (100) 9 (100) 8 (88.9) 6 (66.9)  9 (100) 
Streptococcus pneumoniae  6 (100) 6 (100)  6 (100) 6 (100) 6 (100) 6 (100) 5 (83.3) 5 (83.3)  6 (100) 
Staphylococcus 
epidermidis  
1 (100) 1 (100)   1 (100) 1 (100)  1 (100) 1 (100) 1 (100)  
Streptococcus pyogenes  2 (100) 1 (50)  1 (50) 2 (100) 2 (100) 2 (100)  1 (50) 2 (100) 1 (50) 
Heamophilus influenza  7 (100)   7 (100)  7 (100) 6 (100) 7(100) 7 (100) 4 (66.7) 6 (100) 
Pseudomonas aeruginosa 6 (75) 6 (75) 8 (100) 8 (100) 8 (100) 4 (50)  8 (100) 8 (100) 7 (87.5) 8 (100) 
Klebsiella spp  6 (100)  5 (83.6) 6 (100) 6 (100) 4 (66.7)   6 (100)   
Escherichia coli   2 (100)  2 (100)  1 (50)  2 (100) 2 (100) 1 (50)  
α-Haemolytic 
streptococcus  
1 (100)  1 (100) 1 (100) 1 (100) 1 (100) 1 (100)    1 (100) 
Erythromycin was excluded from Table 7 above as it was staphylococcus epidermidis and streptococcus pneumoniae from 
two specimens that were sensitive to it. 
1 = Pefloxacin, 2 = Ciprofloxacin, 3 = Ofloxacin, 4 = Gentamycin, 5 = Augumentin, 6 = Amoxicillin, 7 = Cloxacillin, 8 = 
Ceftazidime, 9 = Ceftriaxone, 10 = Cefuroxime, 11 = Erythromycin, 12 = Sparfloxacin 
 
DISCUSSION 
Rhinosinusitis is the fifth most common diagnosis 
for which an antibiotic is prescribed and accounted 
for 21% of all adult antibiotic prescriptions (15). 
However, the sensitivity and/or the resistance 
patterns of the predominant pathogens vary 
considerably from region to region (16, 17). 
Therefore, the initial antimicrobial treatment of 
acute rhinosinusitis should be with the most 
narrow-spectrum agent that is active against the 
likely pathogens. In selecting an appropriate 
antibiotic for patients with rhinosinusitis, 
physicians must bear in mind the incidence of 
antibiotic-resistant bacteria in their community and 
consider the patient’s overall health status. Special 
attention should be given to diseases that could 
impede normal recovery from infection and/or 
predispose to complications such as diabetes 
mellitus, chronic pulmonary disease, asthma, cystic 
fibrosis and immune deficiencies. 
 
In this study, acute maxillary sinusitis constituted 
about 18% of the cases. None of these patients have 
co-morbid medical conditions. Studies have shown 
that most cases of maxillary sinusitis will present 
during the chronic phase and only few cases will 
present at the acute phase to physicians (8, 18). The 
relatively low percentage of those with acute 
maxillary sinusitis may be because of the practice of 
self-medication with antibiotics in our environment 
which could have resulted in a complete resolution 
of most of these patients’ symptoms or cure without 




This is supported by the evidence that 73.4% 
participants had history of antibiotic usage before 
presentation. In addition, some of the patients may 
not have severe disease hence would have been 
successfully managed by the General Practitioners 
or Family Physicians who are usually the first 
contact for these patients in hospitals. The 
persistence of the disease beyond 12 weeks will 
result in its chronicity (9, 19-22) as observed in 
about 82% of the participants who presented with 
features of chronic maxillary sinusitis. These may 
be the products of failed initial self-medication with 
a resultant severe form of the disease that has a 
negative impact on the quality of life and 
performance status of these patients.  It could also 
be that the disease started initially as non-infectious 
rhinosinusitis which later became infected. The 
chronic infective maxillary sinusitis may either be 
caused by bacteria or fungal organisms.  
 
Only 57.14% of the cultured maxillary antral 
aspirates from patients with acute maxillary 
sinusitis in this study yielded pathogenic 
organisms.  It is possible that anaerobic organism, 
which was not included in this study because of 
non-availability of funds, was responsible for 
infection in the remaining 42.86% of maxillary 
antral aspirates which did not grow any organism.  
Anaerobic organisms have been reported as causes 
of acute maxillary sinusitis. (19, 21, 23)   Similar 
studies have also reported that bacterial cultures 




cases of acute community acquired sinusitis (24, 25).  
This is similar to the finding in this study.  
 
The spectrum of aerobic bacterial isolates from 
antral specimens of patients with acute maxillary 
sinusitis in this study is similar to what had been 
previously reported in the literature (12, 22, 25-30).  
However, variability exists in the frequencies at 
which these pathogenic organisms occurred. The 
frequency of Streptococcus pneumoniae or 
Haemophilus influenza as a leading cause of acute 
maxillary sinusitis varies from study to study (12, 
22, 25-30).  Streptococcus pneumoniae accounted for 
50% of the isolated pathogen in this study. This was 
followed by Haemophilus influenza in 37.50% and the 
least was Staphylococcus aureus in 12.50%. The low 
frequency of Staphylococcus aureus in this study is 
also similar to what had been reported from a 
similar previous study (31). Staphylococcus aureus 
could be a normal nasal flora in 28 – 35% of healthy 
individuals (32) and if precaution was not taking 
during samples collection, it could contaminate 
maxillary antral aspirates. Staphylococcus aureus 
isolated in this study is likely to be a pathogen 
rather than a contaminant as the specimen was 
aspirated with a canula directly from the maxillary 
antrum into a sterile syringe before being cultured.  
 
Out of the 57 specimens from the maxillary antrum 
of patients with chronic maxillary sinusitis, only 39 
(68.42%) yielded pathogenic aerobic bacterial 
organisms. No growth was found in the culture 
from 18 (31.58%) specimens. Similar studies have 
also reported varied proportion of maxillary antral 
specimens which yielded pathogenic growth as 
observed by Aneke et al (57.41%), and Mantovani et 
al (53.2%) (8, 33). Anaerobic bacteria appear to play 
an important role in patients with chronic paranasal 
sinusitis (12). It is a possibility that anaerobic 
bacteria and other higher organisms, which were 
not included in this study for lack of funds, could 
have been responsible for the infection in these 
patients (42.86%) whose maxillary antral aspirates 
did not grow any aerobic organism. Hence, a 
similar study that will include isolation of anaerobic 
organisms from maxillary antral aspirate is desired.    
Some of these patients’ maxillary antra had an 
initial negative tap or aspirate as at the time of the 
study but this was washed and the aspirate from it 
cultured. The antibiotic abuse among other 
medications by most of our patients could have 
rendered the antrum sterile as at the time of the 
study. Pathogenic anaerobic organisms have been 
isolated with varied frequencies from similar 
studies that included anaerobic isolation from 
maxillary antral specimens of patients with chronic 
maxillary sinusitis (19, 33-35). 
 
The commonest aerobic bacterial isolate from 
chronic maxillary sinusitis in this study was 
Staphylococcus aureus, which constituted 21.43% of 
all isolated bacteria. This has been described as a 
pathogenic cause of chronic infection of the 
paranasal sinuses. (35) Hence, its isolation as a 
pathogen in this study should not be regarded as a 
mere contaminant from a normal nasal flora (8). In a 
similar study by Aneke et al, Staphylococcus aureus 
topped the list of their total isolated pathogenic 
organisms with a frequency of 32.3% respectively 
(8).   
 
Gram negative bacteria constituted the majority 
(54.76%) of the aerobic organisms isolated from the 
maxillary antral specimens of patients with chronic 
maxillary sinusitis in this study and also, 
Pseudomonas aeruginosa constituted 19.05% of all the 
aerobic isolates and 34.78% of the gram negative 
organisms. The predominance of gram negative 
organisms among the aerobic pathogenic agents in 
chronic maxillary sinusitis was also reported in 
similar studies (8, 20, 24, 25). This has been 
attributed to nonhygienic care and misuse of 
antibiotics, a problem in developing countries, 
which generally leads to persistence of resistance 
strains and chronicity. The Haemophilus influenza 
isolated from the maxillary antral aspirates in this 
study had also been reported by other workers (8, 
23). This may be the cause of an acute exacerbation 
of chronic maxillary sinusitis because it has been 
more frequently implicated in acute maxillary 
sinusitis. Streptococcus pyogenes accounted for 4.76% 
of the isolates from this study. No single isolates of 
this organism was demonstrated from the similar 
study in this environment. (8, 25) Staphylococcus 
epidermidis accounted for 2.38% of isolates in this 
study. This has been demonstrated as one of the 
most frequent isolates (normal flora) from the nasal 
cavities of healthy individuals. (36) Alpha-Hemolytic 
Streptococcus was also cultured in one (2.38%) of our 
specimen.   
 
Normal individuals have on the average more than 
two different fungal forms that are present in their 
nasal cavities (37). These could be normal body 
flora or contaminants even though could be 
pathogenic in some immunocompetent patients. 
Thus, over-colonization of the sinuses by fungi can 
also occur in immunocompromised individual with 
resultant opportunistic infections even though it 
was not sought for in this study. The low pH and 
decreased mucociliary clearance will trap the fungal 
spores and mycelia and lead to their growth and 
spread (38).  Many authors have reported varied 
prevalence of fungal infection in chronic 
rhinosinusitis (39-42). In this study, only seven 
maxillary antral specimens yielded fungal growth 
(Table 5). The main fungal organisms isolated were 
Aspergillus and Candida species. Aspergillus spp have 
been isolated more frequently than other fungal 
agents in the maxillary aspirates (41, 42). The abuse 
of antibiotic usage seen in some of our patients 
might have contributed to the opportunistic fungal 




specimen that grew fungus was positive for bacteria 
growth. 
Amoxicillin and trimethoprim-sulfamethoxazole 
[Bactrim, Septrim]) have been recommended for use 
in the management of uncomplicated, acute 
bacterial rhinosinusitis (43, 44). Trimethoprim-
sulfamethoxazole was not included in our antibiotic 
sensitivity pattern as it was observed from our 
institution that most organisms have developed 
resistance to it. This might be because of the abuse 
of the drug which can be easily procured from the 
counter in our environment. All the aerobic 
organisms cultured from the maxillary antral 
aspirate from acute maxillary sinusitis showed 
100% in vitro sensitivity to Amoxicillin and 
Ciprofloxacin (Table 6).  
 
Chronic maxillary sinusitis usually results primarily 
from a non-infective etiology but may have 
secondary superimpose bacteria infections.12 Both 
Gram positive and Gram negative aerobic and 
anaerobic organisms have been reportedly cultured 
from the maxillary antral aspirates of some of these 
patients (25-27). The types of aerobic bacterial 
organisms isolated from this study is similar to 
what had been reported (5,8,12,25). The in vitro 
sensitivity activities of antibiotics against the 
isolated organisms from the maxillary antral 
specimen of patients with chronic maxillary 
sinusitis are shown in Table 7.  
Quinolones (Ciprofloxacin, Pefloxacin and 
Sparfloxacin) and Penicillin based drugs 
(Amoxillin, Augumentin, Ceftriaxone) appear to 
have good sensitivity pattern against most of the 
aerobic bacterial isolates. Gentamycin has 100% 
sensitivity pattern against most of the cultured 
organisms especially gram negative organism. 
However, Staphylococcus aureus and Streptococcus 
pyogenes displayed poor sensitivity to gentamycin. 
Nevertheless, Gentamycin should be used with 
caution as it has some ototoxic and nephrotoxic side 
effects.  
 
Conclusion and Recommendation 
The aerobic bacteria isolated from the acute and 
chronic maxillary sinusitis did not differ much from 
what had been known. However, Streptococcus 
pneumoniae and Staphylococcus aureus were the 
commonest bacterial isolates from the maxillary 
antrum of patients with acute maxillary sinusitis 
and chronic maxillary sinusitis respectively. 
Aspergillus flavus is the commonest fungal 
pathogen. The in vitro antibiotic sensitivity pattern 
varies hence the need for microscopy, culture and 
sensitivity of the antral aspirate in selecting 
appropriate antibiotics for the patients with 
rhinosinusitis. Nevertheless, where microbiologic 
laboratory facilities are unavailable, empirical 
Amoxicillin or Ciprofloxacin can be administered as 
a first line antibiotic therapy in the management of 
bacterial rhinosinusitis.  
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